Dr. Wu Skincare Co., Ltd. / Fundamentals

    Income statement

    Net revenue
    €34.23M
    Cost of goods sold
    €10.24M
    Gross profit
    €23.99M
    SG&A expenses
    €9.76M
    R&D expenses
    €305.48K
    EBITDA
    €14.05M
    D&A
    €235.89K
    EBIT
    €13.92M
    Interest expenses
    €42.73K
    EBT
    €13.78M
    Tax expenses
    €2.85M
    Net income
    €10.92M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€2.65M
    Changes in working capital
    -€2.46M
    Operating cash flow
    €8.14M
    Capex
    €103.53K
    Other investing cash flow
    €35.59M
    Net investing cash flow
    €7.19M
    Total cash dividends paid
    -€11.38M
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    -€2.80M
    Net financing cash flow
    -€14.18M
    Foreign exchange effects
    €0.00
    Net change in cash
    €1.14M
    Cash at end of period
    €6.48M
    Free cash flow
    €8.24M

    Balance sheet

    Cash and cash equivalents
    €6.48M
    Cash and short-term investments
    €28.68M
    Total receivables
    €5.84M
    Inventory
    €5.12M
    Other current assets
    €757.77K
    Total current assets
    €40.40M
    Property, plant & equipment
    €779.02K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €10.10M
    Total non-current assets
    €11.18M
    Total assets
    €51.58M
    Accounts payable
    €1.86M
    Short-term debt
    €279.93K
    Other current liabilities
    €6.83M
    Total current liabilities
    €10.60M
    Long-term debt
    €896.36K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €35.37K
    Total non-current liabilities
    €931.73K
    Total liabilities
    €11.54M
    Common stock
    €12.65M
    Retained earnings
    €10.52M
    Other equity
    €0.00
    Total equity
    €40.05M
    Total liabilities and shareholders' equity
    €51.58M

    Company information

    Market capitalization
    €172.81M
    Employees
    0
    Enterprise Value
    €5.95B

    Company ratios

    Gross margin
    70.1% Much better than peer group: 30.2%
    EBITDA margin
    41.1% Better than peer group: 23.8%
    EBIT margin
    40.7% Much better than peer group: 3.6%
    EBT margin
    40.2% Better than peer group: 33.2%
    Net margin
    31.9% Better than peer group: 21.6%
    ROE
    27.3% Better than peer group: 9.6%
    ROA
    21.2% Better than peer group: 6.5%
    Asset turnover
    66.4% Even with peer group: 67.0%
    FCF margin
    23.5% Much better than peer group: 1.9%
    FCF yield
    4.6%
    Efficiency ratio
    58.9%
    Net sales per employee
    €0.00
    Net income per employee
    €0.00

    Notifications